Literature DB >> 6729824

Reversible inhibition of in vitro epithelial cell proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

J F Gierthy, D Crane.   

Abstract

Subconfluent cultures of a mouse epithelial cell line, which after prolonged subculturing exhibited an elevated saturation density as compared to the original cell line, were treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cultures of cells with or without TCDD grew at equal rates until confluency was reached. At confluency, cultures treated with as little as 10(-11) M TCDD showed a decline in cell proliferation relative to controls as demonstrated by cell enumeration and supported by reduced [3H]thymidine incorporation (both by liquid scintillation spectrometry of whole culture and autoradiography of individual cells). After 14 days of exposure, the saturation density of the treated culture was about 50% of the control culture. This TCDD-induced, increased sensitivity to density-dependent inhibition of replication ( DDIR ) was accompanied by a change from a fusiform morphology in the high-saturation-density control cells to a flat cobblestone appearance in the treated low-saturation-density cells. The nondividing cultures treated for 14 days with 10(-11) M TCDD had the same viability as control cultures. Upon trypsin suspension and reseeding , these formerly quiescent cultures were again capable of growing to high cell density and of again showing susceptibility to TCDD-induced changes in cell growth and morphology. Evidence is presented to suggest that this reversible increase in sensitivity to DDIR and the morphological change are not a consequence of cell growth inhibition. This system may provide the basis for an in vitro model to study the effect of TCDD on the control of replication of these cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729824     DOI: 10.1016/0041-008x(84)90274-6

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 2.  The Ah receptor and the mechanism of dioxin toxicity.

Authors:  J P Landers; N J Bunce
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

3.  New CYP1 genes in the frog Xenopus (Silurana) tropicalis: induction patterns and effects of AHR agonists during development.

Authors:  Maria E Jönsson; Cecilia Berg; Jared V Goldstone; John J Stegeman
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-18       Impact factor: 4.219

Review 4.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

5.  Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J F Gierthy; D W Lincoln
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

6.  Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor.

Authors:  Xiaoqing Chang; Yunxia Fan; Saikumar Karyala; Sandy Schwemberger; Craig R Tomlinson; Maureen A Sartor; Alvaro Puga
Journal:  Mol Cell Biol       Date:  2007-07-02       Impact factor: 4.272

Review 7.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

8.  Ah receptor: relevance of mechanistic studies to human risk assessment.

Authors:  J C Cook; K W Gaido; W F Greenlee
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.